|
03.01.2024 13:47:07
|
ProMIS Neurosciences Appoints Neil Warma As Interim Chief Executive Officer
(RTTNews) - ProMIS Neurosciences Inc. (PMN), a biotechnology company, said on Wednesday that it has appointed its Board member Neil Warma as interim Chief Executive Officer to succeed Gail Farfel, who has stepped down to pursue other opportunities.
Most recently, Warma served as the CEO of Genexine, Inc., a South Korean biotech company.
Earlier, he served in various senior leadership roles at several biotech and pharma companies, including Novartis, Opexa Therapeutics, and I-Mab BioPharma, Inc.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu ProMIS Neurosciences Inc Registered Shsmehr Nachrichten
| Keine Nachrichten verfügbar. |
Analysen zu ProMIS Neurosciences Inc Registered Shsmehr Analysen
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.